A5101980682- Venous Thromboembolism Diagnosis and Management
- Lymphoma Diagnosis and Treatment
- Gastrointestinal Tumor Research and Treatment
- Urinary and Genital Oncology Studies
- Gastric Cancer Management and Outcomes
- Cancer Immunotherapy and Biomarkers
- Bladder and Urothelial Cancer Treatments
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Inflammatory Biomarkers in Disease Prognosis
- Complement system in diseases
- Erythropoietin and Anemia Treatment
- Viral-associated cancers and disorders
- Peptidase Inhibition and Analysis
- Chemotherapy-induced cardiotoxicity and mitigation
- Lung Cancer Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Chronic Obstructive Pulmonary Disease (COPD) Research
Instituto de Investigación Marqués de Valdecilla
2020-2023
Marqués de Valdecilla University Hospital
2019-2023
Hospital Universitario 12 De Octubre
2018-2022
The phase III ToGA trial established cisplatin, fluoropyrimidine and trastuzumab as the standard treatment in HER2-positive advanced gastric cancer (AGC). However, demonstrated HER2-negative AGC, oxaliplatin-based regimens could improve tolerance remaining effective. aim of this was to explore potential activity safety capecitabine, oxaliplatin (XELOX) patients with HER-2 positive cancer. We conducted a multicentre, prospective, non-randomised, non-controlled, open-label national (Spanish)...
<b><i>Background:</i></b> Venous thromboembolism (VTE) is a common complication of cancer. This study aimed to evaluate immature platelet fraction (IPF), mean volume (MPV), P-selectin, D-dimer, and thrombin generation (TG) as predictive biomarkers for VTE further the improvement existing risk assessment models (RAMs). <b><i>Methods:</i></b> A prospective, observational, exploratory was conducted on ambulatory cancer patients with indication...
Background: Episodic dyspnea (ED) is a common problem in patients with advanced lung cancer (LC). However, the prevalence of ED and other related aspects this patient population not known. Objectives: To assess describe prevalence, clinical features, treatment, risk factors for outpatients LC. Design: Multicenter cross-sectional study. Subjects: Consecutive sample adult Measurements: We assessed background (BD), characteristics, triggers, management ED. Potential were through multivariate...